01 1Innopharmax
01 1GADOTERATE MEGLUMINE
01 1Taiwan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-12-30
Pay. Date : 2019-12-17
DMF Number : 34291
Submission : 2019-12-03
Status : Active
Type : II
20
Innopharmax Inc, based in Taiwan, is a pharmaceutical company.
One of their notable products is GADOTERATE MEGLUMINE, with a corresponding US DMF Number 34291.
Remarkably, this DMF maintains an Active status since its submission on December 03, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 30, 2019, and payment made on December 17, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
